Hims & Hers (HIMS) reports earnings after the bell. Hilary Kramer expects a blowout quarter with a “just parabolic” move, but notes that legal issues could dampen the stock. Vance Howard emphasizes its advertising quality and says the company is well-positioned for individualized healthcare. They talk about what’s next for the company and the demand niche it fills.